Stephen Baxter
Stock Analyst at Wells Fargo
(2.44)
# 2,515
Out of 5,051 analysts
218
Total ratings
46.1%
Success rate
-0.76%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintains: Overweight | $185 → $221 | $196.50 | +12.47% | 9 | Nov 5, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $412 → $403 | $315.52 | +27.73% | 14 | Oct 22, 2025 | |
| AGL agilon health | Maintains: Overweight | $5 → $1.5 | $0.84 | +79.13% | 9 | Oct 7, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $267 → $400 | $326.73 | +22.43% | 15 | Oct 7, 2025 | |
| OSCR Oscar Health | Maintains: Underweight | $10 → $14 | $17.20 | -18.60% | 12 | Oct 7, 2025 | |
| MOH Molina Healthcare | Maintains: Overweight | $198 → $231 | $152.30 | +51.67% | 20 | Oct 7, 2025 | |
| HUM Humana | Maintains: Overweight | $344 → $347 | $256.40 | +35.34% | 12 | Oct 7, 2025 | |
| CI The Cigna Group | Maintains: Equal-Weight | $340 → $354 | $263.29 | +34.45% | 9 | Oct 7, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $30 → $41 | $37.04 | +10.69% | 23 | Oct 7, 2025 | |
| CVS CVS Health | Maintains: Overweight | $84 → $103 | $78.80 | +30.71% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $249 | $222.32 | +12.00% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $200 → $238 | $205.47 | +15.83% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $375 → $412 | $471.09 | -12.54% | 16 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2.5 → $3 | $3.83 | -21.57% | 11 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $33 | $32.57 | +1.32% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $772 → $816 | $846.50 | -3.60% | 8 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $31 → $29 | $25.65 | +13.06% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $337 → $354 | $350.68 | +0.95% | 4 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $8.18 | +83.37% | 3 | Apr 29, 2024 |
Cardinal Health
Nov 5, 2025
Maintains: Overweight
Price Target: $185 → $221
Current: $196.50
Upside: +12.47%
Elevance Health
Oct 22, 2025
Maintains: Overweight
Price Target: $412 → $403
Current: $315.52
Upside: +27.73%
agilon health
Oct 7, 2025
Maintains: Overweight
Price Target: $5 → $1.5
Current: $0.84
Upside: +79.13%
UnitedHealth Group
Oct 7, 2025
Maintains: Overweight
Price Target: $267 → $400
Current: $326.73
Upside: +22.43%
Oscar Health
Oct 7, 2025
Maintains: Underweight
Price Target: $10 → $14
Current: $17.20
Upside: -18.60%
Molina Healthcare
Oct 7, 2025
Maintains: Overweight
Price Target: $198 → $231
Current: $152.30
Upside: +51.67%
Humana
Oct 7, 2025
Maintains: Overweight
Price Target: $344 → $347
Current: $256.40
Upside: +35.34%
The Cigna Group
Oct 7, 2025
Maintains: Equal-Weight
Price Target: $340 → $354
Current: $263.29
Upside: +34.45%
Centene
Oct 7, 2025
Maintains: Equal-Weight
Price Target: $30 → $41
Current: $37.04
Upside: +10.69%
CVS Health
Oct 7, 2025
Maintains: Overweight
Price Target: $84 → $103
Current: $78.80
Upside: +30.71%
Oct 7, 2025
Maintains: Overweight
Price Target: $210 → $249
Current: $222.32
Upside: +12.00%
Oct 7, 2025
Maintains: Overweight
Price Target: $200 → $238
Current: $205.47
Upside: +15.83%
Oct 7, 2025
Maintains: Equal-Weight
Price Target: $375 → $412
Current: $471.09
Upside: -12.54%
Oct 7, 2025
Maintains: Underweight
Price Target: $2.5 → $3
Current: $3.83
Upside: -21.57%
Oct 7, 2025
Maintains: Overweight
Price Target: $27 → $33
Current: $32.57
Upside: +1.32%
Sep 24, 2025
Maintains: Equal-Weight
Price Target: $772 → $816
Current: $846.50
Upside: -3.60%
Aug 14, 2025
Maintains: Equal-Weight
Price Target: $31 → $29
Current: $25.65
Upside: +13.06%
Aug 13, 2025
Maintains: Overweight
Price Target: $337 → $354
Current: $350.68
Upside: +0.95%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $8.18
Upside: +83.37%